nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—UGT2B7—Epirubicin—testicular cancer	0.383	0.719	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Ifosfamide—testicular cancer	0.0641	0.12	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Vinblastine—testicular cancer	0.034	0.0639	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Etoposide—testicular cancer	0.0306	0.0575	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—testicular cancer	0.0209	0.0392	CbGbCtD
Chenodeoxycholic acid—Nausea—Dactinomycin—testicular cancer	0.0003	0.000641	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—testicular cancer	0.000299	0.000639	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Etoposide—testicular cancer	0.000299	0.000639	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—testicular cancer	0.000297	0.000635	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—testicular cancer	0.000297	0.000635	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Methotrexate—testicular cancer	0.000297	0.000635	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Ifosfamide—testicular cancer	0.000294	0.000629	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Cisplatin—testicular cancer	0.000294	0.000628	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Doxorubicin—testicular cancer	0.000292	0.000625	CcSEcCtD
Chenodeoxycholic acid—Rash—Ifosfamide—testicular cancer	0.000292	0.000624	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Ifosfamide—testicular cancer	0.000291	0.000623	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Etoposide—testicular cancer	0.00029	0.000621	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—testicular cancer	0.00029	0.00062	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—testicular cancer	0.00029	0.000619	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Epirubicin—testicular cancer	0.000289	0.000618	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Etoposide—testicular cancer	0.000289	0.000618	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Etoposide—testicular cancer	0.000289	0.000618	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—testicular cancer	0.000289	0.000618	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—testicular cancer	0.000289	0.000618	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—testicular cancer	0.000288	0.000616	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Methotrexate—testicular cancer	0.000288	0.000616	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Methotrexate—testicular cancer	0.000287	0.000614	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Cisplatin—testicular cancer	0.000286	0.000612	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—testicular cancer	0.000286	0.000612	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Methotrexate—testicular cancer	0.000286	0.000611	CcSEcCtD
Chenodeoxycholic acid—Sweating—Doxorubicin—testicular cancer	0.000285	0.000609	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—testicular cancer	0.000285	0.000609	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—testicular cancer	0.000284	0.000607	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—testicular cancer	0.000283	0.000606	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—testicular cancer	0.000283	0.000606	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—testicular cancer	0.000283	0.000604	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000281	0.000601	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—testicular cancer	0.00028	0.000599	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Methotrexate—testicular cancer	0.000279	0.000598	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—testicular cancer	0.000279	0.000596	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Methotrexate—testicular cancer	0.000278	0.000595	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—testicular cancer	0.000278	0.000594	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Methotrexate—testicular cancer	0.000278	0.000594	CcSEcCtD
Chenodeoxycholic acid—Chills—Methotrexate—testicular cancer	0.000276	0.000591	CcSEcCtD
Chenodeoxycholic acid—Nausea—Ifosfamide—testicular cancer	0.000275	0.000588	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Cisplatin—testicular cancer	0.000273	0.000583	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Methotrexate—testicular cancer	0.000272	0.000582	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Epirubicin—testicular cancer	0.000269	0.000576	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Etoposide—testicular cancer	0.000269	0.000576	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—testicular cancer	0.000269	0.000575	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Methotrexate—testicular cancer	0.000268	0.000573	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—testicular cancer	0.000268	0.000573	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—testicular cancer	0.000268	0.000572	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—testicular cancer	0.000267	0.000572	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—testicular cancer	0.000267	0.00057	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—testicular cancer	0.000265	0.000566	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—testicular cancer	0.000263	0.000563	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—testicular cancer	0.000263	0.000562	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Etoposide—testicular cancer	0.000262	0.000561	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—testicular cancer	0.000262	0.00056	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—testicular cancer	0.000262	0.000559	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—testicular cancer	0.000261	0.000559	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—testicular cancer	0.00026	0.000557	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—testicular cancer	0.00026	0.000556	CcSEcCtD
Chenodeoxycholic acid—Back pain—Methotrexate—testicular cancer	0.000259	0.000555	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—testicular cancer	0.000259	0.000553	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Etoposide—testicular cancer	0.000258	0.000553	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—testicular cancer	0.000258	0.000551	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—testicular cancer	0.000257	0.00055	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—testicular cancer	0.000255	0.000545	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Cisplatin—testicular cancer	0.000254	0.000542	CcSEcCtD
Chenodeoxycholic acid—Rash—Cisplatin—testicular cancer	0.000251	0.000538	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Cisplatin—testicular cancer	0.000251	0.000537	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—testicular cancer	0.000251	0.000537	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Etoposide—testicular cancer	0.00025	0.000535	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—testicular cancer	0.000249	0.000533	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Methotrexate—testicular cancer	0.000249	0.000532	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—testicular cancer	0.000249	0.000532	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Methotrexate—testicular cancer	0.000248	0.00053	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—testicular cancer	0.000248	0.000529	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—testicular cancer	0.000247	0.000529	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—testicular cancer	0.000246	0.000527	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—testicular cancer	0.000244	0.000521	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—testicular cancer	0.000243	0.000519	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—testicular cancer	0.000242	0.000517	CcSEcCtD
Chenodeoxycholic acid—Malaise—Methotrexate—testicular cancer	0.000242	0.000517	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Etoposide—testicular cancer	0.000242	0.000517	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—testicular cancer	0.000241	0.000516	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—testicular cancer	0.000241	0.000515	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Methotrexate—testicular cancer	0.000241	0.000515	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—testicular cancer	0.00024	0.000514	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Methotrexate—testicular cancer	0.00024	0.000513	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—testicular cancer	0.000239	0.000512	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—testicular cancer	0.000238	0.00051	CcSEcCtD
Chenodeoxycholic acid—Nausea—Cisplatin—testicular cancer	0.000237	0.000507	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—testicular cancer	0.000236	0.000504	CcSEcCtD
Chenodeoxycholic acid—Cough—Methotrexate—testicular cancer	0.000234	0.0005	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—testicular cancer	0.000233	0.000498	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Methotrexate—testicular cancer	0.000232	0.000497	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Etoposide—testicular cancer	0.000232	0.000497	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—testicular cancer	0.000232	0.000497	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—testicular cancer	0.000232	0.000496	CcSEcCtD
Chenodeoxycholic acid—Rash—Etoposide—testicular cancer	0.00023	0.000493	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Etoposide—testicular cancer	0.00023	0.000492	CcSEcCtD
Chenodeoxycholic acid—Headache—Etoposide—testicular cancer	0.000229	0.000489	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—testicular cancer	0.000229	0.000489	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Methotrexate—testicular cancer	0.000228	0.000488	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Methotrexate—testicular cancer	0.000228	0.000488	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Methotrexate—testicular cancer	0.000228	0.000488	CcSEcCtD
Chenodeoxycholic acid—Tension—Doxorubicin—testicular cancer	0.000228	0.000487	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000227	0.000485	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—testicular cancer	0.000226	0.000484	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Methotrexate—testicular cancer	0.000226	0.000482	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—testicular cancer	0.000226	0.000482	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—testicular cancer	0.000225	0.000482	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—testicular cancer	0.000225	0.000481	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—testicular cancer	0.000225	0.00048	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—testicular cancer	0.000225	0.00048	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—testicular cancer	0.000223	0.000477	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Epirubicin—testicular cancer	0.000222	0.000474	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Methotrexate—testicular cancer	0.000221	0.000472	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—testicular cancer	0.000221	0.000472	CcSEcCtD
Chenodeoxycholic acid—Cough—Epirubicin—testicular cancer	0.000219	0.000468	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—testicular cancer	0.000217	0.000465	CcSEcCtD
Chenodeoxycholic acid—Infection—Methotrexate—testicular cancer	0.000217	0.000465	CcSEcCtD
Chenodeoxycholic acid—Nausea—Etoposide—testicular cancer	0.000217	0.000464	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—testicular cancer	0.000217	0.000463	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—testicular cancer	0.000215	0.000461	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Methotrexate—testicular cancer	0.000215	0.000459	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—testicular cancer	0.000215	0.000459	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Methotrexate—testicular cancer	0.000214	0.000458	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—testicular cancer	0.000214	0.000457	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—testicular cancer	0.000214	0.000457	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—testicular cancer	0.000214	0.000457	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Methotrexate—testicular cancer	0.000213	0.000455	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000212	0.000454	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Methotrexate—testicular cancer	0.000212	0.000452	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—testicular cancer	0.000211	0.000451	CcSEcCtD
Chenodeoxycholic acid—Malaise—Doxorubicin—testicular cancer	0.000209	0.000448	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—testicular cancer	0.000209	0.000447	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—testicular cancer	0.000209	0.000446	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Methotrexate—testicular cancer	0.000209	0.000446	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—testicular cancer	0.000208	0.000445	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—testicular cancer	0.000208	0.000444	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Epirubicin—testicular cancer	0.000207	0.000442	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—testicular cancer	0.000205	0.000439	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—testicular cancer	0.000205	0.000438	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Methotrexate—testicular cancer	0.000204	0.000437	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—testicular cancer	0.000204	0.000436	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—testicular cancer	0.000203	0.000435	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—testicular cancer	0.000203	0.000433	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—testicular cancer	0.000201	0.000431	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—testicular cancer	0.000201	0.00043	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—testicular cancer	0.000201	0.000429	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—testicular cancer	0.000201	0.000429	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—testicular cancer	0.0002	0.000429	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—testicular cancer	0.0002	0.000427	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000199	0.000426	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—testicular cancer	0.000199	0.000425	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—testicular cancer	0.000198	0.000423	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Methotrexate—testicular cancer	0.000198	0.000423	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—testicular cancer	0.000198	0.000423	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—testicular cancer	0.000198	0.000423	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—testicular cancer	0.000198	0.000423	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methotrexate—testicular cancer	0.000197	0.00042	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000196	0.00042	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—testicular cancer	0.000195	0.000418	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—testicular cancer	0.000195	0.000417	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Methotrexate—testicular cancer	0.000195	0.000417	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Methotrexate—testicular cancer	0.000195	0.000416	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—testicular cancer	0.000193	0.000413	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Methotrexate—testicular cancer	0.000193	0.000412	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—testicular cancer	0.000191	0.000409	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—testicular cancer	0.000191	0.000409	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Methotrexate—testicular cancer	0.00019	0.000407	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—testicular cancer	0.000189	0.000405	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000189	0.000404	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methotrexate—testicular cancer	0.000189	0.000403	CcSEcCtD
Chenodeoxycholic acid—Infection—Doxorubicin—testicular cancer	0.000188	0.000403	CcSEcCtD
Chenodeoxycholic acid—Pain—Methotrexate—testicular cancer	0.000187	0.0004	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000187	0.000399	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—testicular cancer	0.000186	0.000399	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—testicular cancer	0.000186	0.000397	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—testicular cancer	0.000186	0.000397	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—testicular cancer	0.000185	0.000396	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—testicular cancer	0.000185	0.000395	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—testicular cancer	0.000184	0.000394	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—testicular cancer	0.000184	0.000393	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—testicular cancer	0.000183	0.000392	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—testicular cancer	0.000183	0.00039	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—testicular cancer	0.000182	0.000389	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—testicular cancer	0.000181	0.000386	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Methotrexate—testicular cancer	0.00018	0.000386	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—testicular cancer	0.00018	0.000385	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.000179	0.000383	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—testicular cancer	0.000178	0.000381	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—testicular cancer	0.000177	0.000379	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000177	0.000378	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—testicular cancer	0.000177	0.000378	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—testicular cancer	0.000175	0.000374	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—testicular cancer	0.000175	0.000374	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Methotrexate—testicular cancer	0.000174	0.000372	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Methotrexate—testicular cancer	0.000173	0.00037	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methotrexate—testicular cancer	0.000173	0.00037	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000173	0.000369	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Doxorubicin—testicular cancer	0.000171	0.000366	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—testicular cancer	0.00017	0.000364	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—testicular cancer	0.000169	0.000361	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—testicular cancer	0.000169	0.000361	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—testicular cancer	0.000168	0.00036	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.000167	0.000358	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—testicular cancer	0.000167	0.000357	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—testicular cancer	0.000165	0.000352	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000164	0.00035	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—testicular cancer	0.000163	0.000349	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Epirubicin—testicular cancer	0.000163	0.000348	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—testicular cancer	0.000162	0.000347	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—testicular cancer	0.000162	0.000347	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—testicular cancer	0.000162	0.000346	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—testicular cancer	0.000162	0.000346	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Methotrexate—testicular cancer	0.000161	0.000345	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Methotrexate—testicular cancer	0.000157	0.000336	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—testicular cancer	0.000156	0.000334	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000155	0.000331	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Methotrexate—testicular cancer	0.000155	0.000331	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—testicular cancer	0.000151	0.000323	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—testicular cancer	0.000151	0.000322	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—testicular cancer	0.00015	0.00032	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—testicular cancer	0.00015	0.00032	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Methotrexate—testicular cancer	0.00015	0.00032	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Epirubicin—testicular cancer	0.000147	0.000314	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Epirubicin—testicular cancer	0.000145	0.00031	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Methotrexate—testicular cancer	0.000145	0.000309	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—testicular cancer	0.00014	0.0003	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—testicular cancer	0.00014	0.000299	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Methotrexate—testicular cancer	0.000139	0.000298	CcSEcCtD
Chenodeoxycholic acid—Rash—Methotrexate—testicular cancer	0.000138	0.000295	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methotrexate—testicular cancer	0.000138	0.000295	CcSEcCtD
Chenodeoxycholic acid—Headache—Methotrexate—testicular cancer	0.000137	0.000293	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Doxorubicin—testicular cancer	0.000136	0.000291	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—testicular cancer	0.000135	0.00029	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Doxorubicin—testicular cancer	0.000134	0.000287	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Epirubicin—testicular cancer	0.00013	0.000278	CcSEcCtD
Chenodeoxycholic acid—Nausea—Methotrexate—testicular cancer	0.00013	0.000278	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—testicular cancer	0.00013	0.000277	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—testicular cancer	0.000129	0.000276	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—testicular cancer	0.000129	0.000276	CcSEcCtD
Chenodeoxycholic acid—Headache—Epirubicin—testicular cancer	0.000128	0.000274	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Doxorubicin—testicular cancer	0.000125	0.000268	CcSEcCtD
Chenodeoxycholic acid—Nausea—Epirubicin—testicular cancer	0.000122	0.00026	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Doxorubicin—testicular cancer	0.00012	0.000258	CcSEcCtD
Chenodeoxycholic acid—Rash—Doxorubicin—testicular cancer	0.000119	0.000255	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—testicular cancer	0.000119	0.000255	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—testicular cancer	0.000119	0.000254	CcSEcCtD
Chenodeoxycholic acid—Nausea—Doxorubicin—testicular cancer	0.000113	0.000241	CcSEcCtD
